ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,622.99
      0.49%
      US Tech 100
      19,003.60
      0.40%
      Dow Jones
      41,395.19
      0.73%
      Brent Oil
      72.795
      1.15%
      Bitcoin
      58,180.87
      0.10%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Athersys Inc (ATHX) Quote

      Athersys Inc

      Athersys Inc (ATHX)

      Athersys Inc New (PK)
      0.1018
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.1018
      Bid
      0.101
      Ask
      0.104
      Volume
      -
      0.00 Day's Range 0.00
      0.0938 52 Week Range 39.2325
      Market Cap
      1.831M
      Previous Close
      0.1018
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      17,986,000
      Dividend Yield
      -
      PE Ratio
      -0.02
      Earnings Per Share (EPS)
      -4.03
      Revenue
      5.33M
      Net Profit
      -72.53M

      About Athersys Inc

      Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are foc... Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.athersys.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Athersys Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATHX. The last closing price for Athersys was $0.10. Over the last year, Athersys shares have traded in a share price range of $ 0.0938 to $ 39.2325.

      Athersys currently has 17,986,000 shares outstanding. The market capitalization of Athersys is $1.83 million. Athersys has a price to earnings ratio (PE ratio) of -0.02.

      Ask ADVFN Intelligence (AI)

      ATHX Latest News

      More News

      Form 8-K - Current report

      January 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 22 2023
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 21 2023
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 16 2023
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 18 2023
      Edgar (US Regulatory)

      Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

      Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces it has...

      October 16 2023
      Business Wire

      Form 8-K - Current report

      October 12 2023
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 11 2023
      Edgar (US Regulatory)

      Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios

      The MOU includes $1.5M to $4.5M near term payments plus up to $150M in milestones Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem®...

      October 10 2023
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      October 06 2023
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      26-0.3449-77.21065592120.44670.4757990.093887979640.12358666CS
      52-38.8982-99.7389743593939.23250.093831375918.57182126CS
      156-36.8982-99.724864864937110.50.0938275163728.04306639CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TNONTenon Medical Inc
      $ 9.69
      (120.23%)
      		11.31M
      NOVVNova Vision Acquisition Corporation
      $ 26.17
      (112.25%)
      		30.19k
      ATPCAgape ATP Corporation
      $ 2.795
      (92.76%)
      		51.34M
      NOVVUNova Vision Acquisition Corporation
      $ 25.43
      (90.63%)
      		4.06k
      OMICSingular Genomics Systems Inc
      $ 9.32
      (64.96%)
      		963.87k
      UPCUniverse Pharmaceuticals Inc
      $ 0.535
      (-67.96%)
      		8.67M
      GSIWGarden Stage Ltd
      $ 4.27
      (-65.00%)
      		382.06k
      HCTIHealthcare Triangle Inc
      $ 0.3712
      (-27.53%)
      		269.29k
      OBLGOblong Inc
      $ 4.85
      (-25.84%)
      		1.27M
      GVVisionary Holdings Inc
      $ 3.37
      (-23.76%)
      		714.21k
      XXII22nd Century Group Inc
      $ 0.3725
      (38.32%)
      		106.4M
      IMRXImmuneering Corporation
      $ 2.20
      (53.85%)
      		88.73M
      NVDANVIDIA Corporation
      $ 119.17
      (0.03%)
      		71.56M
      ATPCAgape ATP Corporation
      $ 2.795
      (92.76%)
      		51.34M
      SQQQProShares UltraPro Short QQQ
      $ 8.185
      (-1.15%)
      		31.47M

      Discussion

      View Full Feed
      JusticeWillWin JusticeWillWin 3 minutes ago
      There are many companies paying dividends although they have debt on their balance. By the way, COOP repaid debt in the past and refinanced senior notes. I would be happy receiving a COOP divi soon...

      JWW

      I might not be the sharpest tool in the shed BUTTTTTTTTTTT, don't
      COOP
      ysung ysung 3 minutes ago
      Something going here ???

      Volume keeps coming in on Friday ???
      CNNA
      Heiris Heiris 3 minutes ago
      Hallo
      Ich habe von Simplywall eine Mitteilung über E-Mail bekommen dass am 23.9.24 eine Liquidationszahlung von 0,10 US.Dollar von Coop bezahlt wird !!
      Kannst Du das mal überprüfen?
      Ich bin mit dem Tablet nicht so gut !
      COOP
      Heiris Heiris 3 minutes ago
      Hallo
      Ich habe von Simplywall eine Mitteilung über E-Mail bekommen dass am 23.9.24 eine Liquidationszahlung von 0,10 US.Dollar von Coop bezahlt wird !!
      Kannst Du das mal überprüfen?
      Ich bin mit dem Tablet nicht so gut !
      COOP
      bb72mo bb72mo 4 minutes ago
      I have doubts this stock shares will ever be liquid again. Shame. It had so much potential. Lost a lot of money here.
      IPTK
      solidgold solidgold 4 minutes ago
      I'm here to make money big way and I believe. Time will tell. Good luck to all. $NBRI$
      NBRI
      nilremerlin nilremerlin 4 minutes ago
      https://www.marijuanamoment.net/six-u-s-states-report-setting-new-monthly-marijuana-sales-records/
      AYRWF
      Jack_Herer Jack_Herer 4 minutes ago
      Strategy? I'm not playing this like an actual mineral explorer/developer, although they may turn out to become one. Long shot, though.
      I've already got plenty of those, mostly highly undervalued gold pre-developers with a decent resource at good grade (grade is King, always!).
      If the
      HIRU
      tedpeele tedpeele 4 minutes ago
      I don't think so. There was an immediate outcry by many on the board - and I'd say the consensus was that they would have taken those onlyif there was a very large deal in the works, and so expectations were high for a deal to be announced at the upcoming 2022 ASM.

      Remember, that $5.
      ASM
      dstock07734 dstock07734 4 minutes ago
      Just realized I had a typo. It should be *diseases instead of leases.

      You don't need to wait for the potential to be fully tapped. None of us either. The partnership and franchise deals will send the sp to the stratosphere right away. I also mentioned about that DCVax-L will be the c
      NWBO
      burner67 burner67 4 minutes ago
      Or get out
      RONN
      DredLock DredLock 4 minutes ago
      🤣 Well said! Lol
      IGPK
      Knowledge is King Knowledge is King 4 minutes ago
      ADFJF revealed a $40M backlog discrepancy on the phone with you?!


      Put me down as skeptical...
      RedSox04 RedSox04 4 minutes ago
      He’s clueless and doesn’t know how to trade and got bagged and posts here non stop everyday all he does is bash
      CBDL
      glenn1919 glenn1919 4 minutes ago
      ATPC.......................https://stockcharts.com/h-sc/ui?s=ATPC&p=W&b=5&g=0&id=p86431144783
      ATPC
      SCAMBUSTERKING SCAMBUSTERKING 4 minutes ago
      My plan hasn't changed, the date is Feb '25. I don't set the court dates, BCAP PPS keeps dropping, not sure how you think you are winning here 🤣
      BCAP
      Gumpstein Gumpstein 4 minutes ago
      What's the next move Destiny/Dark Alpha? Your only move and shareholders (if you care) only hope is to sell the shell to someone that does care, is legit and has potential. You have "tried" a weed company, a trucking logistics company, and an AI company. Time to surrender and let someone else "try".
      HENC
      QuicKtip QuicKtip 4 minutes ago
      $CBDW 1606 Corp’s IR Chat is revolutionizing investor relations by offering real-time support, providing investors with immediate access to insights on financials, filings, and strategic initiatives.

      https://cbdw.ai/
      CBDW
      QuicKtip QuicKtip 4 minutes ago
      $CBDW 1606 Corp’s IR Chat is revolutionizing investor relations by offering real-time support, providing investors with immediate access to insights on financials, filings, and strategic initiatives.

      https://cbdw.ai/
      CBDW
      tnyellowtomcat tnyellowtomcat 5 minutes ago
      Back above .05 on the bid!

      Hope springs ETERNAL!!

      Think positive thoughts! Picture in your mind a success and higher stock prices! Tap into the Force! "Let the Force be with you!"

      "See the ball, be the ball, make ... make it happen"

      VB
      LQMT
      winnotlose winnotlose 5 minutes ago
      Ddd. Heading north
      CountOfMeltedCrisco CountOfMeltedCrisco 5 minutes ago
      The Three Amigos all have a looooooooooong way to go
      Historically, Palladium reached an all time high of 3440.76 in March of 2022.
      The highest platinum price was $2,213 on March 3, 2008
      Silver's all-time high is $49.45, which was the metal's price on January 18, 1980.
      I
      NBRI
      Bearslayer Bearslayer 6 minutes ago
      No answers. The report has to be written. It will be out in an 8k in four days. I had additional shares I found and tried to vote no during the 2 minute span allowed and it never recorded. Doesn’t matter anyway. The fix was in.
      RXMD
      StayHumble StayHumble 6 minutes ago
      w0w NO R/S+MERGER AQUISITION 🟩Huzzah onDECK Yowza!
      https://x.com/CorporateUbqu/status/1765510100628726105?s=20
      https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
      UBQU
      Kmacneill116 Kmacneill116 6 minutes ago
      Sorry blackturd $$$
      RNVA

      Your Recent History

      NASDAQ
      ATHX
      Athersys
      Delayed Upgrade Clock